Market Whales and Their Recent Bets on VKTX Options
Market Whales and Their Recent Bets on VKTX Options
Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics (NASDAQ:VKTX).
有大量資金可以花的投資者對Viking Therapeutics（納斯達克股票代碼：VKTX）採取了看跌立場。
And retail traders should know.
零售交易者應該知道。
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
今天，當我們在本辛加追蹤的公開期權歷史記錄中出現頭寸時，我們注意到了這一點。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VKTX, it often means somebody knows something is about to happen.
無論這些是機構還是僅僅是富人，我們都不知道。但是，當 VKTX 發生這麼大的事情時，通常意味着有人知道某件事即將發生。
Today, Benzinga's options scanner spotted 10 options trades for Viking Therapeutics.
今天，Benzinga的期權掃描儀發現了Viking Therapeutics的10筆期權交易。
This isn't normal.
這不正常。
The overall sentiment of these big-money traders is split between 20% bullish and 80%, bearish.
這些大手交易者的整體情緒分爲20％看漲和80％（看跌）。
Out of all of the options we uncovered, there was 1 put, for a total amount of $63,900, and 9, calls, for a total amount of $718,259.
在我們發現的所有期權中，有1個看跌期權，總額爲63,900美元，還有9個看漲期權，總額爲718,259美元。
What's The Price Target?
目標價格是多少？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $55.0 to $90.0 for Viking Therapeutics during the past quarter.
通過分析這些合約的交易量和未平倉合約，大型企業似乎一直在考慮在過去一個季度中將Viking Therapeutics的價格範圍從55.0美元到90.0美元不等。
Volume & Open Interest Development
交易量和未平倉合約的發展
In today's trading context, the average open interest for options of Viking Therapeutics stands at 1655.67, with a total volume reaching 2,742.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Viking Therapeutics, situated within the strike price corridor from $55.0 to $90.0, throughout the last 30 days.
在今天的交易背景下，維京療法期權的平均未平倉合約爲1655.67份，總成交量達到2742.00。隨附的圖表描繪了過去30天Viking Therapeutics高價值交易的看漲期權和看跌期權交易量以及未平倉合約的變化，行使價走勢從55.0美元到90.0美元不等。
Viking Therapeutics Option Activity Analysis: Last 30 Days
Viking Therapeutics 期權活動分析：過去 30 天
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BULLISH | 05/17/24 | $3.1 | $2.9 | $3.1 | $75.00 | $310.0K | 2.2K | 10 |
| VKTX | CALL | SWEEP | BEARISH | 04/19/24 | $10.8 | $10.2 | $10.2 | $55.00 | $106.0K | 4.7K | 242 |
| VKTX | CALL | TRADE | NEUTRAL | 05/17/24 | $3.1 | $2.9 | $3.0 | $75.00 | $75.0K | 2.2K | 1.0K |
| VKTX | CALL | TRADE | BEARISH | 04/19/24 | $11.3 | $10.1 | $10.3 | $55.00 | $69.0K | 4.7K | 112 |
| VKTX | PUT | SWEEP | BEARISH | 04/19/24 | $1.0 | $0.75 | $1.0 | $65.00 | $63.9K | 1.8K | 699 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 打電話 | 貿易 | 看漲 | 05/17/24 | 3.1 美元 | 2.9 美元 | 3.1 美元 | 75.00 美元 | 310.0 萬美元 | 2.2K | 10 |
| VKTX | 打電話 | 掃 | 粗魯的 | 04/19/24 | 10.8 美元 | 10.2 美元 | 10.2 美元 | 55.00 美元 | 106.0 萬美元 | 4.7K | 242 |
| VKTX | 打電話 | 貿易 | 中立 | 05/17/24 | 3.1 美元 | 2.9 美元 | 3.0 美元 | 75.00 美元 | 75.0 萬美元 | 2.2K | 1.0K |
| VKTX | 打電話 | 貿易 | 粗魯的 | 04/19/24 | 11.3 美元 | 10.1 | 10.3 美元 | 55.00 美元 | 69.0 萬美元 | 4.7K | 112 |
| VKTX | 放 | 掃 | 粗魯的 | 04/19/24 | 1.0 美元 | 0.75 美元 | 1.0 美元 | 65.00 美元 | 63.9 萬美元 | 1.8K | 699 |
About Viking Therapeutics
關於維京療法
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家醫療保健服務提供商。該公司專門從事以代謝和內分泌失調爲重點的生物藥品開發領域。該公司的臨床項目管道包括 VK2809、VK5211、VK0214 產品。VK2809 和 VK0214 是可口服的甲狀腺激素受體 β 的組織和受體亞型選擇性激動劑。VK5211 是一種口服的非甾體選擇性雄激素受體調節劑。
Where Is Viking Therapeutics Standing Right Now?
Viking Therapeutics 現在處於什麼位置？
- Trading volume stands at 800,529, with VKTX's price down by -1.64%, positioned at $65.38.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 6 days.
- 交易量爲800,529美元，其中VKTX的價格下跌了-1.64％，爲65.38美元。
- RSI指標顯示，該股目前在超買和超賣之間處於中立狀態。
- 預計將在6天后公佈業績。
What The Experts Say On Viking Therapeutics
專家對維京療法的看法
In the last month, 4 experts released ratings on this stock with an average target price of $122.75.
上個月，4位專家發佈了該股的評級，平均目標價爲122.75美元。
- In a cautious move, an analyst from HC Wainwright & Co. downgraded its rating to Buy, setting a price target of $90.
- An analyst from Oppenheimer has decided to maintain their Outperform rating on Viking Therapeutics, which currently sits at a price target of $138.
- An analyst from Oppenheimer has decided to maintain their Outperform rating on Viking Therapeutics, which currently sits at a price target of $138.
- Maintaining their stance, an analyst from BTIG continues to hold a Buy rating for Viking Therapeutics, targeting a price of $125.
- HC Wainwright & Co. 的一位分析師謹慎地將其評級下調至買入，將目標股價定爲90美元。
- 奧本海默的一位分析師已決定維持對Viking Therapeutics的跑贏大盤評級，該評級目前的目標股價爲138美元。
- 奧本海默的一位分析師已決定維持對Viking Therapeutics的跑贏大盤評級，該評級目前的目標股價爲138美元。
- BTIG的一位分析師堅持其立場，繼續維持對Viking Therapeutics的買入評級，目標價格爲125美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比，期權是一種風險更高的資產，但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。